Alliance Community Oncology Network
Official title: Alliance NCORP Research Base
Funded at Alliance Nctn Foundation · NIH-11337885 · Data updated 2026-11-12
This national program runs clinical trials and patient studies to find better ways to prevent cancer, ease treatment side effects, and improve cancer care for people with or at risk for cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Alliance Nctn Foundation NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | August 1, 2014 |
| Project end | July 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $7,877,673 |
| NIH project number | 3UG1CA189823-11S3 |
| Project ID | NIH-11337885 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with or at risk for cancer who receive care at participating Alliance NCORP community or academic sites — including patients with bone or brain metastases when relevant trials are open — are typical candidates.
✕Less likely to help
Patients whose cancer type, stage, or care site is not included in an active trial at their local NCORP site may not be eligible or see direct benefit.
What this research studies
This program is a national network that runs many cancer prevention, symptom-control, and care-delivery studies through both community hospitals and academic centers. As a patient, you might be invited to join treatment trials, supportive-care studies, quality-of-life surveys, or database projects that collect health information and samples. The network works with patient representatives and focuses on questions that matter to people living with cancer. Over many years the group has published hundreds of papers and led to practice-changing findings in areas such as preventing chemo-induced nausea, reducing bone complications from metastases, and improving care for brain metastases.
Why it matters
Potential benefit: If successful, this work could mean better prevention, fewer treatment side effects, and more patient-centered cancer care.
How similar studies have gone: The Alliance NCORP has already produced many successful, practice-changing results, including advances in preventing chemotherapy nausea, limiting skeletal complications from bone metastases, and managing brain metastases.
Where this research is happening
-
Alliance Nctn Foundation
Chicago, United States Active
Researchers
- Principal investigator: Paskett, Electra D. — Alliance Nctn Foundation
- Study coordinator: Paskett, Electra D.
Related research
Other NIH-funded projects on the same topics.
-
Alliance NCORP Research Base for Community Cancer Trials
A nationwide program working with community clinics to test new cancer treatments and care approaches for patients with cancer, including those with bone, brain, or bone-metastatic disease.
-
Alliance for Clinical Trials in Oncology Membership Core
This grant supports a national cancer trials network to make it easier for patients, including teens and young adults, to access high-quality clinical trials.
-
Alliances for Cancer Trials: Clinical Trials Core
A collaboration network helps speed up cancer trials to bring new therapies and better care to patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.